AMDCP Credit Designation: Thiss ession has been approved for a total of 3 Clinical credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): Barbara J.Messinger-Rapport, MD, PhD, CMD; Julie Gammack, MD, CMD; John Morley, MB, BCh;David Thomas, MD Disclosure(s): Barbara J. Messinger-Rapport, MD, PhD, CMD received speaker honoraria from Forest Pharmaceuticals, Inc. and Novartis. Products made by these companies related to this topic: Reclase and Namenda. John Morley, MB, BCH received grant/research Support from Ascend, Baxter, Numico, Nestle, and Danone and onthe Speaker's Bureau at Merck & Co, Novartis, Indevus,Orthobiotec, GTx, Amgen,Novartis Nutritional and Mattern. He is a consultantfor Novartis, Mattern Pharmaceuticals Amgen, Edunn Biotec, Indevus,Abbott, Glaxo Smith Kline, Cytokinetics,Ligand, and Baxter and has stocks in Mattern Pharm and Edunn Biotec.
Allother presenters reported they had no relevant financial relationships todisclose.
Session Description: This session presents the latest and sometimes controversialapproaches to medical conditions commonly found in frail elders in thecontinuum of care, particularly in nursing facility. Topics addressed at thissession include dysphagia, constipation, cachexia, dehydration, hypertension,and heart failure. Information is presented in a didactic format withopportunities for questions from the audience. Learning Objectives:
Identify different methods of preventing aspiration in dysphagia
Understand the different approach to diastolic heart failure, the mostcommon type of heart failure in the older adult
Suggest treatments for constipation
References: BJ Messinger-Rapport, JE Morley, DR Thomas, JK Gammack.Intensive Session: New approaches to medical issues in long-term care. JAMDA.2007. 8(7):421-433